These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 33322077

  • 1. A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel.
    França F, Silva PMA, Soares JX, Henriques AC, Loureiro DRP, Azevedo CMG, Afonso CMM, Bousbaa H.
    Molecules; 2020 Dec 10; 25(24):. PubMed ID: 33322077
    [Abstract] [Full Text] [Related]

  • 2. Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
    Silva PM, Ribeiro N, Lima RT, Andrade C, Diogo V, Teixeira J, Florindo C, Tavares Á, Vasconcelos MH, Bousbaa H.
    Cancer Lett; 2017 May 28; 394():33-42. PubMed ID: 28249757
    [Abstract] [Full Text] [Related]

  • 3. BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity.
    Novais P, Silva PMA, Moreira J, Palmeira A, Amorim I, Pinto M, Cidade H, Bousbaa H.
    Molecules; 2021 Nov 25; 26(23):. PubMed ID: 34885726
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents.
    Kamal A, Mallareddy A, Suresh P, Shaik TB, Lakshma Nayak V, Kishor C, Shetti RV, Sankara Rao N, Tamboli JR, Ramakrishna S, Addlagatta A.
    Bioorg Med Chem; 2012 Jun 01; 20(11):3480-92. PubMed ID: 22543234
    [Abstract] [Full Text] [Related]

  • 5. 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells.
    Levrier C, Sadowski MC, Rockstroh A, Gabrielli B, Kavallaris M, Lehman M, Davis RA, Nelson CC.
    Mol Cancer Ther; 2017 Jan 01; 16(1):3-15. PubMed ID: 27760837
    [Abstract] [Full Text] [Related]

  • 6. Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone.
    Palmeira A, Paiva A, Sousa E, Seca H, Almeida GM, Lima RT, Fernandes MX, Pinto M, Vasconcelos MH.
    Chem Biol Drug Des; 2010 Jul 01; 76(1):43-58. PubMed ID: 20456373
    [Abstract] [Full Text] [Related]

  • 7. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
    Henriques AC, Ribeiro D, Pedrosa J, Sarmento B, Silva PMA, Bousbaa H.
    Cancer Lett; 2019 Jan 01; 440-441():64-81. PubMed ID: 30312726
    [Abstract] [Full Text] [Related]

  • 8. Antagonizing the spindle assembly checkpoint silencing enhances paclitaxel and Navitoclax-mediated apoptosis with distinct mechanistic.
    Henriques AC, Silva PMA, Sarmento B, Bousbaa H.
    Sci Rep; 2021 Feb 18; 11(1):4139. PubMed ID: 33603057
    [Abstract] [Full Text] [Related]

  • 9. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.
    Russell P, Hennessy BT, Li J, Carey MS, Bast RC, Freeman T, Venkitaraman AR.
    Oncogene; 2012 May 10; 31(19):2450-60. PubMed ID: 22056875
    [Abstract] [Full Text] [Related]

  • 10. Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton.
    Steinmetz MO, Prota AE.
    Trends Cell Biol; 2018 Oct 10; 28(10):776-792. PubMed ID: 29871823
    [Abstract] [Full Text] [Related]

  • 11. An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.
    Wang X, Wu E, Wu J, Wang TL, Hsieh HP, Liu X.
    PLoS One; 2013 Oct 10; 8(6):e65686. PubMed ID: 23762410
    [Abstract] [Full Text] [Related]

  • 12. Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.
    Mäki-Jouppila JH, Laine LJ, Rehnberg J, Narvi E, Tiikkainen P, Hukasova E, Halonen P, Lindqvist A, Kallio L, Poso A, Kallio MJ.
    Mol Cancer Ther; 2014 May 10; 13(5):1054-66. PubMed ID: 24748653
    [Abstract] [Full Text] [Related]

  • 13. Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types.
    Spanò V, Rocca R, Barreca M, Giallombardo D, Montalbano A, Carbone A, Raimondi MV, Gaudio E, Bortolozzi R, Bai R, Tassone P, Alcaro S, Hamel E, Viola G, Bertoni F, Barraja P.
    J Med Chem; 2020 Oct 22; 63(20):12023-12042. PubMed ID: 32986419
    [Abstract] [Full Text] [Related]

  • 14. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
    Li PK, Pandit B, Sackett DL, Hu Z, Zink J, Zhi J, Freeman D, Robey RW, Werbovetz K, Lewis A, Li C.
    Mol Cancer Ther; 2006 Feb 22; 5(2):450-6. PubMed ID: 16505120
    [Abstract] [Full Text] [Related]

  • 15. MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules.
    Zhang Z, Meng T, He J, Li M, Tong LJ, Xiong B, Lin L, Shen J, Miao ZH, Ding J.
    Invest New Drugs; 2010 Dec 22; 28(6):715-28. PubMed ID: 19705064
    [Abstract] [Full Text] [Related]

  • 16. The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis.
    Salmela AL, Pouwels J, Kukkonen-Macchi A, Waris S, Toivonen P, Jaakkola K, Mäki-Jouppila J, Kallio L, Kallio MJ.
    Exp Cell Res; 2012 Mar 10; 318(5):578-92. PubMed ID: 22227008
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS, Choi HE, Shin JS, Cho YW, Choi JH, Cho WJ, Lee KT.
    Carcinogenesis; 2013 Aug 10; 34(8):1852-60. PubMed ID: 23615402
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Target driven preclinical screening for new antimitotic chemotherapy agents.
    Novío S, Freire-Garabal M, Núñez MJ.
    Curr Top Med Chem; 2014 Aug 10; 14(20):2263-71. PubMed ID: 25434356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.